229 related articles for article (PubMed ID: 38198116)
1. Demystifying Dry Powder Inhaler Resistance with Relevance to Optimal Patient Care.
Capstick TGD; Gudimetla S; Harris DS; Malone R; Usmani OS
Clin Drug Investig; 2024 Feb; 44(2):109-114. PubMed ID: 38198116
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
[TBL] [Abstract][Full Text] [Related]
3. [Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)].
Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1055-1067. PubMed ID: 37914418
[TBL] [Abstract][Full Text] [Related]
4. A narrative review on the Synchrobreathe™: A novel breath-actuated pressurised metered-dose inhaler for the treatment of obstructive airway diseases.
Lavorini F; Usmani OS; Salvi S; Rote K; Gaur V; Gogtay J
Respir Med; 2023; 219():107435. PubMed ID: 38652077
[TBL] [Abstract][Full Text] [Related]
5. The clinical relevance of dry powder inhaler performance for drug delivery.
Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
[TBL] [Abstract][Full Text] [Related]
6. Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases?
Scichilone N; Benfante A; Bocchino M; Braido F; Paggiaro P; Papi A; Santus P; Sanduzzi A
Pulm Pharmacol Ther; 2015 Apr; 31():63-7. PubMed ID: 25724817
[TBL] [Abstract][Full Text] [Related]
7. Optimizing drug delivery in COPD: The role of inhaler devices.
Rogliani P; Calzetta L; Coppola A; Cavalli F; Ora J; Puxeddu E; Matera MG; Cazzola M
Respir Med; 2017 Mar; 124():6-14. PubMed ID: 28284323
[TBL] [Abstract][Full Text] [Related]
8. High inhaler resistance does not limit successful inspiratory maneuver among patients with asthma or COPD.
Vartiainen VA; Lavorini F; Murphy AC; Rabe KF
Expert Opin Drug Deliv; 2023 Mar; 20(3):385-393. PubMed ID: 36820500
[TBL] [Abstract][Full Text] [Related]
9. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
[TBL] [Abstract][Full Text] [Related]
10. Misuse and/or treatment delivery failure of inhalers among patients with asthma or COPD: A review and recommendations for the conduct of future research.
Mahon J; Fitzgerald A; Glanville J; Dekhuijzen R; Glatte J; Glanemann S; Torvinen S
Respir Med; 2017 Aug; 129():98-116. PubMed ID: 28732842
[TBL] [Abstract][Full Text] [Related]
11. Dry Powder Inhalers: From Bench to Bedside.
Chrystyn H; Azouz W; Tarsin W
J Aerosol Med Pulm Drug Deliv; 2023 Dec; 36(6):324-335. PubMed ID: 38016124
[TBL] [Abstract][Full Text] [Related]
12. What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis.
Lavorini F; Bianco A; Blasi F; Braido F; Corsico AG; Di Marco F; Gentile A; Paggiaro PL; Pegoraro V; Pelaia G; Rogliani P; Santus P; Scichilone N; Soldi A; Canonica GW
Respir Med; 2020 May; 166():105937. PubMed ID: 32250870
[TBL] [Abstract][Full Text] [Related]
13. Inhalation therapy devices for the treatment of obstructive lung diseases: the history of inhalers towards the ideal inhaler.
Sorino C; Negri S; Spanevello A; Visca D; Scichilone N
Eur J Intern Med; 2020 May; 75():15-18. PubMed ID: 32113944
[TBL] [Abstract][Full Text] [Related]
14. Inhalatory therapy training: a priority challenge for the physician.
Melani AS
Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
[TBL] [Abstract][Full Text] [Related]
15. The dry powder inhaler features of the Easyhaler that benefit the management of patients.
Chrystyn H; Lavorini F
Expert Rev Respir Med; 2020 Apr; 14(4):345-351. PubMed ID: 32013627
[No Abstract] [Full Text] [Related]
16. Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma.
Brocklebank D; Wright J; Cates C
BMJ; 2001 Oct; 323(7318):896-900. PubMed ID: 11668133
[TBL] [Abstract][Full Text] [Related]
17. [Inhalers and inhalation techniques in the treatment of asthma and chronic obstructive pulmonary disease].
Fuglø-Mortensen R; Lange P; Mortensen J
Ugeskr Laeger; 2019 Aug; 181(33):. PubMed ID: 31495355
[TBL] [Abstract][Full Text] [Related]
18. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients.
Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R
Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733
[TBL] [Abstract][Full Text] [Related]
19. Device-handling study of a novel breath-actuated inhaler, Synchrobreathe®, versus a pMDI.
Balamurugan S; Apte K; Singh BP; Deb AK; Deshmukh C; Modi K; Godse A; Dhar R; Lahiri KR; Singh V; Pandya H; Rajan S; Vaidya A; Gaur V; Gogtay J
Respir Med; 2020 Jan; 161():105707. PubMed ID: 32056719
[TBL] [Abstract][Full Text] [Related]
20. Novolizer: how does it fit into inhalation therapy?
Magnussen H
Curr Med Res Opin; 2005; 21 Suppl 4():S39-46; discussion S47. PubMed ID: 16138944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
